Loading...
Phreesia, Inc.
PHR•NYSE
Healthcare
Medical - Healthcare Information Services
$26.63
$-0.42(-1.55%)
Phreesia, Inc. (PHR) Financial Performance & Income Statement Overview
Review Phreesia, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
26.84%
↑ 26.84%
Operating Income Growth
25.36%
↑ 25.36%
Net Income Growth
22.29%
↑ 22.29%
Operating Cash Flow Growth
64.07%
↑ 64.07%
Operating Margin
-9.66%
↓ 9.66%
Gross Margin
66.29%
↑ 66.29%
Net Profit Margin
-9.83%
↓ 9.83%
ROE
-16.23%
↓ 16.23%
ROIC
-14.49%
↓ 14.49%
Phreesia, Inc. (PHR) Income Statement & Financial Overview
Review Phreesia, Inc.'s (PHR) income statement with detailed quarterly and annual figures.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $109.68M | $106.80M | $102.11M | $101.22M |
| Cost of Revenue | $33.57M | $34.54M | $40.31M | $40.88M |
| Gross Profit | $76.11M | $72.26M | $61.81M | $60.33M |
| Gross Profit Ratio | $0.69 | $0.68 | $0.61 | $0.60 |
| R&D Expenses | $29.63M | $29.32M | $29.54M | $28.88M |
| SG&A Expenses | $47.28M | $49.70M | $49.68M | $50.87M |
| Operating Expenses | $76.90M | $86.11M | $79.03M | $79.75M |
| Total Costs & Expenses | $93.41M | $120.64M | $119.34M | $120.64M |
| Interest Income | $0.00 | $0.00 | $654000.00 | $792000.00 |
| Interest Expense | $0.00 | $0.00 | $608000.00 | $553000.00 |
| Depreciation & Amortization | $6.93M | $7.09M | $7.50M | $6.87M |
| EBITDA | $2.14M | -$6.27M | -$9.16M | -$11.79M |
| EBITDA Ratio | $0.02 | -$0.06 | -$0.09 | -$0.12 |
| Operating Income | -$7.61M | -$13.84M | -$17.22M | -$19.42M |
| Operating Income Ratio | -$0.07 | -$0.13 | -$0.17 | -$0.19 |
| Other Income/Expenses (Net) | $2.24M | -$118000.00 | -$40000.00 | $208000.00 |
| Income Before Tax | -$5.38M | -$13.96M | -$17.26M | -$19.21M |
| Income Before Tax Ratio | -$0.05 | -$0.13 | -$0.17 | -$0.19 |
| Income Tax Expense | $1.01M | $442000.00 | $750000.00 | $510000.00 |
| Net Income | -$6.39M | -$14.40M | -$18.01M | -$19.72M |
| Net Income Ratio | -$0.06 | -$0.13 | -$0.18 | -$0.19 |
| EPS | -$0.11 | $0.65 | -$0.31 | -$0.35 |
| Diluted EPS | -$0.11 | $0.65 | -$0.31 | -$0.35 |
| Weighted Avg Shares Outstanding | $58.28M | $57.89M | $57.50M | $56.67M |
| Weighted Avg Shares Outstanding (Diluted) | $58.28M | $57.89M | $57.50M | $56.67M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan